1. Home
  2. VISN vs KARD Comparison

VISN vs KARD Comparison

Compare VISN & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vistance Networks Inc. Common Stock

VISN

Vistance Networks Inc. Common Stock

N/A

Current Price

$3.84

Market Cap

1.4B

Sector

Technology

ML Signal

N/A

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$11.60

Market Cap

1.5B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VISN
KARD
Founded
1976
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2013
2026

Fundamental Metrics

Financial Performance
Metric
VISN
KARD
Price
$3.84
$11.60
Analyst Decision
Hold
Strong Buy
Analyst Count
4
9
Target Price
$5.67
★ $41.00
AVG Volume (30 Days)
★ 7.1M
441.3K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
★ 412.50%
N/A
EPS Growth
★ 641.01
N/A
EPS
★ 29.48
N/A
Revenue
★ $1,931,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.14
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.89
$12.23
52 Week High
$19.91
$27.00

Technical Indicators

Market Signals
Indicator
VISN
KARD
Relative Strength Index (RSI) 25.48 35.74
Support Level N/A N/A
Resistance Level $6.76 $16.26
Average True Range (ATR) 0.25 1.30
MACD -0.09 -0.24
Stochastic Oscillator 1.79 0.60

Price Performance

Historical Comparison
VISN
KARD

About VISN Vistance Networks Inc. Common Stock

Vistance Networks Inc operates in the communications technology sector, providing solutions designed to support the delivery and management of communications services. It serves customers globally through teams involved in product development, implementation, and customer support. The company designs and develops network infrastructure and connectivity solutions focused on reliability and performance. Its offerings include intelligent networking technologies intended to support evolving communication requirements.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: